Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703480 · ClinicalTrials.gov registry record · NA
Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques
A NA study of Vertical Alveolar Bone Loss, sponsored by Tufts University.
- Active
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT02703480: Active NA study of Vertical Alveolar Bone Loss, sponsored by Tufts University.
NCT02703480 is a NA study of Vertical Alveolar Bone Loss that is active but no longer recruiting, run by Tufts University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02703480, a NA study of Vertical Alveolar Bone Loss, is active but no longer recruiting, sponsored by Tufts University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed study design is a randomized controlled trial, split mouth design, to compare the two different vertical augmentation procedures: Titanium mesh (Ti-mesh) technique and Guided Bone Regeneration (GBR) technique with a high-density polytetrafluoroethylene (d-PTFE) membrane.
Conditions Studied
Interventions
- BIOLOGICAL d-PTFE
- BIOLOGICAL Ti-mesh
Study Locations (1)
Massachusetts
- Tufts University School of Dental Medicine - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2015-12 |
| Est. Completion | 2025-06 |
| Phase | NA |
What the registry record for NCT02703480 still lists
NCT02703480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Vertical Alveolar Bone Loss appearing as the primary indexed condition, and to 2 interventions - of which d-PTFE is the first listed.
NCT02703480 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02703480 about?
NCT02703480 is a clinical study titled "Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques". The proposed study design is a randomized controlled trial, split mouth design, to compare the two different vertical augmentation procedures: Titanium mesh (Ti-mesh) technique and Guided Bone Regeneration (GBR) technique with a high-density polytetrafluoroethylene (d-PTFE) membrane.
What is the current status of trial NCT02703480?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2015-12. Estimated completion is 2025-06.
What conditions does trial NCT02703480 study?
This clinical trial studies the following conditions: Vertical Alveolar Bone Loss.
What interventions are being tested in trial NCT02703480?
The interventions under investigation include: d-PTFE (BIOLOGICAL), Ti-mesh (BIOLOGICAL).
Who is sponsoring clinical trial NCT02703480?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02703480 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02703480's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia